| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2000-105087 | 2000-04-06 | ||
| JP2000105087 | 2000-04-06 | ||
| PCT/JP2001/002981WO2001076630A1 (en) | 2000-04-06 | 2001-04-06 | Diagnostics and remedies for rheumatoid arthritis |
| Publication Number | Publication Date |
|---|---|
| AU2001246850A1true AU2001246850A1 (en) | 2001-10-23 |
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2001246850AAbandonedAU2001246850A1 (en) | 2000-04-06 | 2001-04-06 | Diagnostics and remedies for rheumatoid arthritis |
| Country | Link |
|---|---|
| US (2) | US20030152572A1 (en) |
| EP (1) | EP1275398A4 (en) |
| AU (1) | AU2001246850A1 (en) |
| CA (1) | CA2404919A1 (en) |
| WO (1) | WO2001076630A1 (en) |
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20130056201A (en) | 2000-05-19 | 2013-05-29 | 제넨테크, 인크. | Gene detection assay for improving the likelihood of an effective response to an erbb antagonist cancer therapy |
| TWI324597B (en)* | 2002-03-28 | 2010-05-11 | Astrazeneca Ab | Quinazoline derivatives |
| PT1667992E (en)* | 2003-09-19 | 2007-04-30 | Astrazeneca Ab | Quinazoline derivatives |
| WO2005089800A1 (en)* | 2004-03-17 | 2005-09-29 | Locomogene, Inc. | PHARMACEUTICAL COMPOSITION CONTAINING hsHRD3 |
| KR20150083139A (en) | 2005-01-21 | 2015-07-16 | 제넨테크, 인크. | Fixed dosing of her antibodies |
| DK1850874T3 (en) | 2005-02-23 | 2013-11-11 | Genentech Inc | Extension of time to disease progression or survival for ovarian cancer using pertuzumab |
| KR20080009695A (en)* | 2005-05-06 | 2008-01-29 | 가부시키가이샤 아미노 압 가가쿠 | Health food and pharmaceutical composition for improving cartilage metabolic disorder |
| JP2006316040A (en) | 2005-05-13 | 2006-11-24 | Genentech Inc | Herceptin(r) adjuvant treatment |
| US7416889B2 (en)* | 2006-04-27 | 2008-08-26 | Rhode Island Hospital | Methods and compositions for repairing cartilage |
| NZ578824A (en) | 2007-03-02 | 2012-03-30 | Genentech Inc | Predicting response to a her dimerisation inhibitor based on low her3 expression |
| AU2008234615B2 (en) | 2007-04-02 | 2013-10-10 | Philogen S.P.A. | The ED-A antigen of fibrinogen is associated with the neovasculature of tumour metastases |
| SI2171090T1 (en)* | 2007-06-08 | 2013-07-31 | Genentech, Inc. | Gene expression markers of tumor resistance to her2 inhibitor treatment |
| US9551033B2 (en) | 2007-06-08 | 2017-01-24 | Genentech, Inc. | Gene expression markers of tumor resistance to HER2 inhibitor treatment |
| US10202442B2 (en) | 2007-07-25 | 2019-02-12 | Philogen S.P.A. | Antigen associated with lung cancers and lymphomas |
| EA017995B1 (en)* | 2007-07-25 | 2013-04-30 | Филоджен С.П.А. | An antigen associated with lung cancers and lymphomas |
| ES2646228T3 (en)* | 2007-10-30 | 2017-12-12 | Philogen S.P.A. | An antigen associated with rheumatoid arthritis |
| EA019183B1 (en) | 2008-05-13 | 2014-01-30 | Астразенека Аб | Fumarate salt of 4-(3-chloro-2-fluoroanilino)-7-methoxy-6-{[1-(n-methylcarbamoylmethyl)piperidin-4-yl]oxy}quinazoline |
| BRPI0812682A2 (en) | 2008-06-16 | 2010-06-22 | Genentech Inc | metastatic breast cancer treatment |
| KR20150036824A (en) | 2009-03-20 | 2015-04-07 | 제넨테크, 인크. | Bispecific anti-her antibodies |
| WO2010136569A1 (en) | 2009-05-29 | 2010-12-02 | F. Hoffmann-La Roche Ag | Modulators for her2 signaling in her2 expressing patients with gastric cancer |
| WO2011015333A2 (en) | 2009-08-05 | 2011-02-10 | Philogen S.P.A. | Targeting of bone marrow neovasculature |
| MY160556A (en) | 2010-02-18 | 2017-03-15 | Genentech Inc | Neuregulin antagonists and use thereof in treating cancer |
| WO2011146568A1 (en) | 2010-05-19 | 2011-11-24 | Genentech, Inc. | Predicting response to a her inhibitor |
| US20130245233A1 (en) | 2010-11-24 | 2013-09-19 | Ming Lei | Multispecific Molecules |
| JP5766296B2 (en) | 2010-12-23 | 2015-08-19 | エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ | Polypeptide-polynucleotide complexes and their use in targeted delivery of effector components |
| CN103890007A (en) | 2011-08-17 | 2014-06-25 | 霍夫曼-拉罗奇有限公司 | Neuregulin antibodies and uses thereof |
| US9327023B2 (en) | 2011-10-25 | 2016-05-03 | The Regents Of The University Of Michigan | HER2 targeting agent treatment in non-HER2-amplified cancers having HER2 expressing cancer stem cells |
| BR112014012979A2 (en) | 2011-11-30 | 2020-10-20 | Genentech, Inc. | erbb3 mutations in cancer |
| EP2788500A1 (en) | 2011-12-09 | 2014-10-15 | F.Hoffmann-La Roche Ag | Identification of non-responders to her2 inhibitors |
| CN104220457A (en) | 2012-03-27 | 2014-12-17 | 霍夫曼-拉罗奇有限公司 | Diagnosis and treatments relating to her3 inhibitors |
| ES2743423T3 (en) | 2012-10-03 | 2020-02-19 | Philogen Spa | Conjugated antibodies for use in the treatment of an inflammatory bowel disease |
| BR112015012644A2 (en) | 2012-11-30 | 2017-12-19 | Hoffmann La Roche | method for determining a cancer patient's need, cancer treatment method, pharmaceutical composition, use of a nucleic acid or antibody and kit; |
| EP3454863A1 (en) | 2016-05-10 | 2019-03-20 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Combinations therapies for the treatment of cancer |
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4828991A (en)* | 1984-01-31 | 1989-05-09 | Akzo N.V. | Tumor specific monoclonal antibodies |
| WO1989006692A1 (en)* | 1988-01-12 | 1989-07-27 | Genentech, Inc. | Method of treating tumor cells by inhibiting growth factor receptor function |
| WO1993000917A1 (en)* | 1991-07-05 | 1993-01-21 | Seragen, Inc. | Epidermal growth factor receptor targeted molecules for treatment of inflammatory arthritis |
| WO1993009788A1 (en)* | 1991-11-13 | 1993-05-27 | Baylor College Of Medicine | Triplex forming oligonucleotide reagents targeted to the neu oncogene promoter and method of use |
| CA2120745A1 (en)* | 1992-06-30 | 1994-01-06 | Philip G. Kasprzyk | A combination of anti-erbb-2 monoclonal antibodies and method of using |
| DE69432315T2 (en)* | 1993-12-23 | 2004-02-12 | Biognostik Gesellschaft für Biomolekulare Diagnostik mbH | ANTISENSE NUCLEIC ACIDS FOR PREVENTING AND TREATING COMPLAINTS IN WHICH THE EXPRESSION OF C-ERBB-2 PLAYS A ROLE |
| AU1831395A (en)* | 1994-01-14 | 1995-08-01 | Cell Therapeutics, Inc. | Method for treating diseases mediated by cellular proliferation in response to pdgf, egf, fgf and vegf |
| GB9510757D0 (en)* | 1994-09-19 | 1995-07-19 | Wellcome Found | Therapeuticaly active compounds |
| US5763470A (en)* | 1995-06-07 | 1998-06-09 | Sugen Inc. | Benzopyran compounds and methods for their use |
| GB9514265D0 (en)* | 1995-07-13 | 1995-09-13 | Wellcome Found | Hetrocyclic compounds |
| DE69634900T2 (en)* | 1995-09-11 | 2006-05-18 | Osteoarthritis Sciences, Inc., Cambridge | PROTEINTYROSINE KINASEINHIBITORS FOR THE TREATMENT OF OSTEOARTHRITIS |
| AR004010A1 (en)* | 1995-10-11 | 1998-09-30 | Glaxo Group Ltd | HETERO CYCLIC COMPOUNDS |
| US6395282B1 (en)* | 1998-04-16 | 2002-05-28 | University Of Rochester | Immunogenic conjugates of Gram-negative bacterial autoinducer molecules |
| EP1114860A4 (en)* | 1998-09-18 | 2002-12-18 | Kyowa Hakko Kogyo Kk | METHOD FOR DIAGNOSING A CELL PROLIFERATIVE DISEASE |
| Publication number | Publication date |
|---|---|
| WO2001076630A1 (en) | 2001-10-18 |
| US20030152572A1 (en) | 2003-08-14 |
| US20060188501A1 (en) | 2006-08-24 |
| CA2404919A1 (en) | 2002-10-01 |
| EP1275398A1 (en) | 2003-01-15 |
| EP1275398A4 (en) | 2004-09-01 |
| Publication | Publication Date | Title |
|---|---|---|
| AU2001246850A1 (en) | Diagnostics and remedies for rheumatoid arthritis | |
| AU2002230997A1 (en) | Methods and compositions for diagnosing and treating rheumatoid arthritis | |
| AU2002213831A1 (en) | Actuating member and method for producing the same | |
| AU2001260728A1 (en) | On demand contents providing method and system | |
| AU2001238278A1 (en) | System and method for programming oscillators | |
| AU2001247478A1 (en) | Microlaboratory devices and methods | |
| AU2002228807A1 (en) | Inspection system | |
| AU2001245975A1 (en) | Systems and methods for providing distributed cross-enterprise portals | |
| AU2001213042A1 (en) | Kneading device and forming device | |
| AU2001232201A1 (en) | Pharmaceutical compositions and methods for treating rheumatoid arthritis | |
| AU2001262431A1 (en) | Multiterminal publishing system and corresponding method for using same | |
| AU2002357180A1 (en) | Timing system and device and method for making the same | |
| AU2001279850A1 (en) | Method and arrangement for studsystem | |
| AU2001287934A1 (en) | Document feeder and method | |
| AU2002213227A1 (en) | Generalizer system and method | |
| AU2001275473A1 (en) | Epoxy resing and process for making the same | |
| AU2001293091A1 (en) | Piezoelectric transformer and operating method | |
| AU2001213027A1 (en) | Contents providing method | |
| AU4465101A (en) | Contents providing system | |
| AU2000240749A1 (en) | System and method for the automation of expense reports | |
| AU2887001A (en) | Web page providing method and system for providing the same | |
| AU2001242801A1 (en) | Input method for characters and the like | |
| AU4479101A (en) | The pyrolysis waste rycycling method and system | |
| AU2001249748A1 (en) | Corba jellybeans system and method | |
| AU2002245027A1 (en) | Electronic voting system |